lidocaine has been researched along with Hepatitis C in 6 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the role played by the immune system in the outcome of chronic C virus infection, we studied the peripheral blood lymphocyte subsets in patients with chronic hepatitis C and the correlation with the hepatic function assessed by the lidocaine test." | 5.08 | [The peripheral blood lymphocyte subpopulations in chronic anti-HCV-positive liver disease: their significance and correlation with liver function]. ( Biceglia, O; De Biasio, MC; De Crescenzo, OD; Forte, GB; Minerva, A; Paceli, M; Rocco, P, 1996) |
| "Lidocaine half-life was significantly lower in HIV-patients without ART." | 1.35 | Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy. ( Beste, M; Gerken, G; Kahraman, A; Miller, M; Ross, B, 2009) |
| "Around 20% of the haemophiliacs developed post-oral surgical complications, which was not significantly different whether or not they were HIV-infected." | 1.31 | Complications in HIV-infected and non-HIV-infected haemophiliacs and other patients after oral surgery. ( Dios, RD; Giangrande, PL; Scully, C; Watt-Smith, P, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, M | 1 |
| Kahraman, A | 1 |
| Ross, B | 1 |
| Beste, M | 1 |
| Gerken, G | 1 |
| Scully, C | 1 |
| Watt-Smith, P | 1 |
| Dios, RD | 1 |
| Giangrande, PL | 1 |
| Taliani, G | 1 |
| Duca, F | 1 |
| Lecce, R | 1 |
| Livoli, D | 1 |
| Pasquazzi, C | 1 |
| De Bac, C | 1 |
| Ziebell, J | 1 |
| Shaw-Stiffel, TA | 1 |
| Campo, N | 1 |
| Alvarez, S | 1 |
| Borzone, S | 1 |
| Caglieris, S | 1 |
| Zentilin, P | 1 |
| Testa, R | 1 |
| Rocco, P | 1 |
| Biceglia, O | 1 |
| Paceli, M | 1 |
| Minerva, A | 1 |
| De Biasio, MC | 1 |
| De Crescenzo, OD | 1 |
| Forte, GB | 1 |
1 trial available for lidocaine and Hepatitis C
| Article | Year |
|---|---|
[The peripheral blood lymphocyte subpopulations in chronic anti-HCV-positive liver disease: their significance and correlation with liver function].
Topics: Adult; Biopsy; Female; Hepatitis C; Hepatitis, Chronic; Humans; Lidocaine; Liver; Liver Cirrhosis; L | 1996 |
5 other studies available for lidocaine and Hepatitis C
| Article | Year |
|---|---|
Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy.
Topics: Adult; Antiviral Agents; Female; Galactose; Half-Life; Hepatitis B; Hepatitis C; HIV Infections; Hum | 2009 |
Complications in HIV-infected and non-HIV-infected haemophiliacs and other patients after oral surgery.
Topics: Adult; Ambulatory Surgical Procedures; Anesthetics, Local; Carticaine; Dry Socket; Female; Heart Dis | 2002 |
Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis.
Topics: Adult; Aged; Fatty Liver; Female; Hepatitis C; Humans; Lidocaine; Liver; Male; Middle Aged | 1995 |
Quantitative liver testing with MEG-X: more optimism?
Topics: Autoimmune Diseases; Biopsy; Hepatitis; Hepatitis C; Lidocaine; Liver; Reproducibility of Results | 1995 |
Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
Topics: Adult; Esophagitis, Peptic; Hepatitis C; Hepatitis, Chronic; Humans; Lidocaine; Male; Mixed Function | 1994 |